The CUL7/F-box and WD repeat domain containing 8 (CUL7/ Fbxw8) ubiquitin ligase promotes degradation of hematopoietic progenitor kinase 1

Journal of Biological Chemistry

Volumn 289, Issue 7, 2014, Pages 4009-4017

  Wang, Huamin ^a   Chen, Yue ^a   Lin, Ping ^a,b   Li, Lei ^a,c   Zhou, Guisheng ^d   Liu, Guangchao ^a   Logsdon, Craig ^e   Jin, Jianping ^a   Abbruzzese, James L ^a   Tan, Tse Hua ^f  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^f NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CUL7 UBIQUITIN LIGASE; E3 UBIQUITIN LIGASE; FBXW8; HPK1; MAP KINASES (MAPKS); PANCREATIC CANCER; PP4; PROTEASOME; PROTEIN PHOSPHATASE; SERINE THREONINE PROTEIN KINASE;

CELL DIFFERENTIATION; CELL PROLIFERATION; CULLIN PROTEINS; F-BOX PROTEINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; JURKAT CELLS; MAP KINASE SIGNALING SYSTEM; MUTATION; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; PHOSPHOPROTEIN PHOSPHATASES; PROTEIN-SERINE-THREONINE KINASES; PROTEOLYSIS;

EID: 84894130517     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.520106     Document Type: Article

References (40)

1. Hu, M. C.-T., Qiu, W. R., Wang, X., Meyer, C. F., and Tan, T.-H. (1996) Human HPK1, a novel human hematopoietic progenitor kinase that activates the JNK/SAPK kinase cascade. Genes Dev. 10, 2251-2264
2. Kiefer, F., Tibbles, L. A., Anafi, M., Janssen, A., Zanke, B. W., Lassam, N., Pawson, T., Woodgett, J. R., and Iscove, N. N. (1996) HPK1, a hematopoietic protein kinase activating the SAPK/JNK pathway. EMBO J. 15, 7013-7025
3. Anafi, M., Kiefer, F., Gish, G. D., Mbamalu, G., Iscove, N. N., and Pawson, T. (1997) SH2/SH3 adaptor proteins can link tyrosine kinases to a Ste20-related protein kinase, HPK1. J. Biol. Chem. 272, 27804-27811
4. Liu, S. K., Smith, C. A., Arnold, R., Kiefer, F., and McGlade, C. J. (2000) The adaptor protein Gads (Grb2-related adaptor downstream of Shc) is implicated in coupling hemopoietic progenitor kinase-1 to the activated TCR. J. Immunol. 165, 1417-1426
5. Ling, P., Meyer, C. F., Redmond, L. P., Shui, J.-W., Davis, B., Rich, R. R., Hu, M. C.-T., Wange, R. L., and Tan, T.-H. (2001) Involvement of hematopoietic progenitor kinase 1 (HPK1) in T-cell receptor (TCR) signaling. J. Biol. Chem. 276, 18908-18914
6. Ling, P., Yao, Z., Meyer, C. F., Wang, X. S., Oehrl, W., Feller, S. M., and Tan, T.-H. (1999) Interaction of hematopoietic progenitor kinase 1 with adapter proteins Crk and CrkL leads to synergistic activation of c-Jun N-terminal kinase. Mol. Cell. Biol. 19, 1359-1368
7. Wang, W., Zhou, G., Hu, M. C.-T., Yao, Z., and Tan, T.-H. (1997) Activation of the hematopoietic progenitor kinase-1 (HPK1)-dependent, stressactivated c-Jun N-terminal kinase (JNK) pathway by transforming growth factor b (TGF-b)-activated kinase (TAK1), a kinase mediator of TGF b signal transduction. J. Biol. Chem. 272, 22771-22775
8. Zhou, G., Lee, S. C., Yao, Z., and Tan, T.-H. (1999) Hematopoietic progenitor kinase 1 is a component of transforming growth factor b-induced c-Jun N-terminal kinase signaling cascade. J. Biol. Chem. 274, 13133-13138
9. Nagata, Y., Kiefer, F., Watanabe, T., and Todokoro, K. (1999) Activation of hematopoietic progenitor kinase-1 by erythropoietin. Blood 93, 3347-3354
10. Arnold, R., Patzak, I. M., Neuhaus, B., Vancauwenbergh, S., Veillette, A., Van Lint, J., and Kiefer, F. (2005) Activation of hematopoietic progenitor kinase 1 involves relocation, autophosphorylation, and transphosphorylation by protein kinase D1. Mol. Cell. Biol. 25, 2364-2383
11. Sawasdikosol, S., Pyarajan, S., Alzabin, S., Matejovic, G., and Burakoff, S. J. (2007) Prostaglandin E2 activates HPK1 kinase activity via a PKA-dependent pathway. J. Biol. Chem. 282, 34693-34699
12. Liou, J., Kiefer, F., Dang, A., Hashimoto, A., Cobb, M. H., Kurosaki, T., and Weiss, A. (2000) HPK1 is activated by lymphocyte antigen receptors and negatively regulates AP-1. Immunity 12, 399-408
13. Tsuji, S., Okamoto, M., Yamada, K., Okamoto, N., Goitsuka, R., Arnold, R., Kiefer, F., and Kitamura, D. (2001) B cell adaptor containing Src homology 2 domain (BASH) links B cell receptor signaling to the activation of hematopoietic progenitor kinase 1. J. Exp. Med. 194, 529-539
14. Yu, J., Riou, C., Davidson, D., Minhas, R., Robson, J. D., Julius, M., Arnold, R., Kiefer, F., and Veillette, A. (2001) Synergistic regulation of immunoreceptor signaling by SLP-76-related adaptor Clnk and serine/threonine protein kinase HPK-1. Mol. Cell. Biol. 21, 6102-6112
15. Sauer, K., Liou, J., Singh, S. B., Yablonski, D., Weiss, A., and Perlmutter, R. M. (2001) The kinase HPK1 associates physically and functionally with the adaptor proteins BLNK and SLP-76 in lymphocytes. J. Biol. Chem. 276, 45207-45216
16. Chen-Deutsch, X., and Studzinski, G. P. (2012) Dual role of hematopoietic progenitor kinase 1 (HPK1) as a positive regulator of 1,25-dihydroxyvitamin D-induced differentiation and cell cycle arrest of AML cells and as a mediator of vitamin D resistance. Cell Cycle 11, 1364-1373
17. Shui, J. W., Boomer, J. S., Han, J., Xu, J., Dement, G. A., Zhou, G., and Tan, T. H. (2007) Hematopoietic progenitor kinase 1 negatively regulates T cell receptor signaling and T cell-mediated immune responses. Nat Immunol 8, 84-91
18. Arnold, R., Liou, J., Drexler, H. C., Weiss, A., and Kiefer, F. (2001) Caspasemediated cleavage of hematopoietic progenitor kinase 1 (HPK1) converts an activator of NFkB into an inhibitor of NFkB. J. Biol. Chem. 276, 14675-14684
19. Oehrl, W., Kardinal, C., Ruf, S., Adermann, K., Groffen, J., Feng, G. S., Blenis, J., Tan, T.-H., and Feller, S. M. (1998) The germinal center kinase (GCK)-related protein kinases HPK1 and KHS are candidates for highly selective signal transducers of Crk family adapter proteins. Oncogene 17, 1893-1901
20. Wang, H., Song, X., Logsdon, C., Zhou, G., Evans, D. B., Abbruzzese, J. L., Hamilton, S. R., and Tan, T. H. (2009) Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer. Cancer Res. 69, 1063-1070
21. Chen, Y.-R., Meyer, C. F., Ahmed, B., Yao, Z., and Tan, T.-H. (1999) Caspase-mediated cleavage and functional changes of hematopoeitic progenitor kinase 1 (HPK1). Oncogene 18, 7370-7377
22. Zhou, G., Boomer, J. S., and Tan, T. H. (2004) Protein phosphatase 4 is a positive regulator of hematopoietic progenitor kinase 1. J. Biol. Chem. 279, 49551-49561
23. Hershko, A., and Ciechanover, A. (1998) The ubiquitin system. Annu. Rev. Biochem. 67, 425-479
24. Deshaies, R. J. (1999) SCF and Cullin/Ring H2-based ubiquitin ligases. Annu. Rev. Cell Dev. Biol. 15, 435-467
25. Petroski, M. D., and Deshaies, R. J. (2005) Function and regulation of cullin-RING ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 6, 9-20
26. Jin, J., Cardozo, T., Lovering, R. C., Elledge, S. J., Pagano, M., and Harper, J. W. (2004) Systematic analysis and nomenclature of mammalian F-box proteins. Genes Dev. 18, 2573-2580
27. Cardozo, T., and Pagano, M. (2004) The SCF ubiquitin ligase: insights into a molecular machine. Nat. Rev. Mol. Cell Biol. 5, 739-751
28. Xu, X., Sarikas, A., Dias-Santagata, D. C., Dolios, G., Lafontant, P. J., Tsai, S. C., Zhu, W., Nakajima, H., Nakajima, H. O., Field, L. J., Wang, R., and Pan, Z. Q. (2008) The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation. Mol. Cell 30, 403-414
29. Yao, Z., Zhou, G., Wang, X. S., Brown, A., Diener, K., Gan, H., and Tan, T. H. (1999) A novel human STE20-related protein kinase, HGK, that specifically activates the c-Jun N-terminal kinase signaling pathway. J. Biol. Chem. 274, 2118-2125
30. Yang, W. L., Wang, J., Chan, C. H., Lee, S. W., Campos, A. D., Lamothe, B., Hur, L., Grabiner, B. C., Lin, X., Darnay, B. G., and Lin, H. K. (2009) The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science 325, 1134-1138
31. Liang, J. J., Wang, H., Rashid, A., Tan, T. H., Hwang, R. F., Hamilton, S. R., Abbruzzese, J. L., Evans, D. B., and Wang, H. (2008) Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. Clin. Cancer Res. 14, 7043-7049
32. Mansour, M. R., Sanda, T., Lawton, L. N., Li, X., Kreslavsky, T., Novina, C. D., Brand, M., Gutierrez, A., Kelliher, M. A., Jamieson, C. H., von Boehmer, H., Young, R. A., and Look, A. T. (2013) The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia. J. Exp. Med. 210, 1545-1557
33. Okabe, H., Lee, S. H., Phuchareon, J., Albertson, D. G., McCormick, F., and Tetsu, O. (2006) A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation. PloS one 1, e128
34. Litterman, N., Ikeuchi, Y., Gallardo, G., O'Connell, B. C., Sowa, M. E., Gygi, S. P., Harper, J. W., and Bonni, A. (2011) An OBSL1-Cul7Fbxw8 ubiquitin ligase signaling mechanism regulates Golgi morphology and dendrite patterning. PLoS Biol. 9, e1001060
35. Kim, S. S., Shago, M., Kaustov, L., Boutros, P. C., Clendening, J. W., Sheng, Y., Trentin, G. A., Barsyte-Lovejoy, D., Mao, D. Y., Kay, R., Jurisica, I., Arrowsmith, C. H., and Penn, L. Z. (2007) CUL7 is a novel antiapoptotic oncogene. Cancer Res. 67, 9616-9622
36. Jung, P., Verdoodt, B., Bailey, A., Yates, J. R., 3rd, Menssen, A., and Hermeking, H. (2007) Induction of cullin 7 by DNA damage attenuates p53 function. Proc. Natl. Acad. Sci. U. S. A. 104, 11388-11393
37. Wang, Z., Inuzuka, H., Fukushima, H., Wan, L., Gao, D., Shaik, S., Sarkar, F. H., and Wei, W. (2011) Emerging roles of the FBW7 tumour suppressor in stem cell differentiation. EMBO Rep. 13, 36-43
38. Paradis, V., Albuquerque, M., Mebarki, M., Hernandez, L., Zalinski, S., Quentin, S., Belghiti, J., Soulier, J., and Bedossa, P. (2013) Cullin7: a new gene involved in liver carcinogenesis related to metabolic syndrome. Gut 62, 911-919
39. Pérez-Mancera, P. A., Rust, A. G., van der Weyden, L., Kristiansen, G., Li, A., Sarver, A. L., Silverstein, K. A., Grützmann, R., Aust, D., Rümmele, P., Knösel, T., Herd, C., Stemple, D. L., Kettleborough, R., Brosnan, J. A., Morgan, R., Knight, S., Yu, J., Stegeman, S., Collier, L. S., ten Hoeve, J. J., de Ridder, J., Klein, A. P., Goggins, M., Hruban, R. H., Chang, D. K., Biankin, A. V., Grimmond, S. M., Wessels, L. F., Wood, S. A., Iacobuzio-Donahue, C. A., Pilarsky, C., Largaespada, D. A., Adams, D. J., and Tuveson, D. A. (2012) The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. Nature 486, 266-270
40. Wu, J., Jiao, Y., Dal Molin, M., Maitra, A., de Wilde, R. F., Wood, L. D., Eshleman, J. R., Goggins, M. G., Wolfgang, C. L., Canto, M. I., Schulick, R. D., Edil, B. H., Choti, M. A., Adsay, V., Klimstra, D. S., Offerhaus, G. J., Klein, A. P., Kopelovich, L., Carter, H., Karchin, R., Allen, P. J., Schmidt, C. M., Naito, Y., Diaz, L. A., Jr., Kinzler, K. W., Papadopoulos, N., Hruban, R. H., and Vogelstein, B. (2011) Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc. Natl. Acad. Sci. U. S. A. 108, 21188-21193